跳至主要内容
临床试验/CTRI/2013/05/003681
CTRI/2013/05/003681招募中不适用

A GLOBAL, MULTICENTER, PROSPECTIVE, REAL WORLD OBSERVATIONAL STUDY FOR LEFT MAIN DISEASE TREATMENT

SeungJung Park1 个研究点 分布在 1 个国家目标入组 10,000 人开始时间: 2011年6月29日最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
10,000
试验地点
1
主要终点
The primary objective is measured in terms of major cardiac and cerebrovascular event (MACCE)-free survival at two year follow-up after index treatment.

研究概览

简要总结

This study is a multicenter, large clinical registry to evaluate comparative outcomes of medical therapy, PCI with DES, or CABG for patients with unprotected LMCA stenosis in the Asia-Pacific, as recorded in the MAIN-IRIS Registry. Data will be prospectively collected on approximately 10000 subjects who diagnosed LM disease (>50% by visual estimation) at approximately 65 centers in Korea and Asia-Pacific region.

The primary objective of this study is:

To observe clinical courses for long-term in patients with unprotected LMCA disease and to evaluate comparative results of medical treatment, coronary stenting with drug-eluting stents, and CABG for the treatment of an unprotected LMCA stenosis in the “real world†daily practice.

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 99.00 Year(s)(—)
性别
All

入选标准

  • •Significant unprotected left main stenosis (>50% by visual estimation) â—¦The LMCA is considered unprotected if there are no patent coronary artery bypass grafts to the left anterior descending artery or the left circumflex artery.
  • •No limitation of clinical or lesion characteristics •Age >18 years •The patient or guardian agrees to the study protocol and the schedule of clinical follow-up, and provides informed, written consent, as approved by the appropriate Institutional Review Board/Ethics Committee of the respective clinical site.

排除标准

  • •Protected left main stenosis.

结局指标

主要结局

The primary objective is measured in terms of major cardiac and cerebrovascular event (MACCE)-free survival at two year follow-up after index treatment.

时间窗: 2year

Non-fatal myocardial infarction (Q wave and non-Q wave)

时间窗: 2year

Target vessel revascularization (TVR) either percutaneous or surgical treatment

时间窗: 2year

Death (all-cause mortality)

时间窗: 2year

Stroke

时间窗: 2year

次要结局

  • All cause death.(Cardiac death.)

研究者

发起方
SeungJung Park
申办方类型
Other [sponsor-investigator]

研究点 (1)

Loading locations...

相似试验

A GLOBAL, MULTICENTER, PROSPECTIVE, REAL WORLD... | 临床试验